Finance

Mga Listahan
DHR:NYSE
Danaher Corp
$224.69
0.00%
(0.00) 1D
Okt 14, 4:04:09 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa DHR...
Mkt. cap
157.95B
Avg. na dami
4.20M
Dami
2.48K
Dividend
0.71%
Bawat tatlong buwang dividend
$0.40
Petsa ng ex-dividend
Set 30, 2026
P/E ratio
39.89
Mataas nang 52-wk
$242.80
Mababa nang 52-wk
$160.93
EPS
$5.63
Beta
0.77
Mga natitirang share
702.99M
Bilang ng mga empleyado
59K
Mkt. cap
157.95B
Avg. na dami
4.20M
Dami
2.48K
Dividend
0.71%
Bawat tatlong buwang dividend
$0.40
Petsa ng ex-dividend
Set 30, 2026
P/E ratio
39.89
Mataas nang 52-wk
$242.80
Mababa nang 52-wk
$160.93
EPS
$5.63
Beta
0.77
Mga natitirang share
702.99M
Bilang ng mga empleyado
59K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Tungkol sa Danaher Corp
CEORainer M. Blair
Mga Empleyado59K
Itinatag1969
Headquarters-
Sektor-
Mga rating ng analyst
Batay sa 17 (na) analyst na nagbigay ng mga rating ng stock sa DHR sa nakalipas na 3 buwan
Strong buy
Pagbili
16
Pag-hold
1
Pagbebenta
0
12 buwang forecas
Batay sa 17 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa DHR sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $224.69
$255.00 (+13.49%)
Average
$235.31 (+4.73%)
Pinakamababa
$200.00 (-10.99%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Daniel Brennan
TD Cowen
Buy
Maintained
$255.00
+13.5%
10/13/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Reiterated
$240.00
+6.8%
10/13/2026
Lu Li
Bank of America Securities
Buy
Maintained
$255.00
+13.5%
10/09/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
$255.00
+13.5%
10/09/2026
Luke Sergott
Barclays
Buy
Maintained
$255.00
+13.5%
10/07/2026
Evie Koslosky
Goldman Sachs
Buy
Maintained
$250.00
+11.3%
10/05/2026
Dan Leonard
RBC Capital
Buy
Maintained
$250.00
+11.3%
10/04/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$250.00
+11.3%
10/01/2026
Joanne Wuensch
Citi
Buy
Maintained
$230.00
+2.4%
09/21/2026
Tycho Peterson
Jefferies
Buy
Maintained
$210.00
-6.5%
09/18/2026
Doug Schenkel
UBS
Buy
Initiated
$250.00
+11.3%
09/13/2026
David Westenberg
Piper Sandler
Hold
Maintained
$200.00
-11%
07/27/2026
David Toung
Argus Research
Buy
Reiterated
$230.00
+2.4%
07/23/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
$220.00
-2.1%
07/23/2026
Justin Bowers
Deutsche Bank
Buy
Reiterated
$240.00
+6.8%
07/22/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/22/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$220.00
-2.1%
07/22/2026
Patrick B Donnelly
Citi
Buy
Maintained
$230.00
+2.4%
07/22/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$195.00
-13.2%
07/22/2026
Aristotelis Moutopoulos
DZ BANK AG
Buy
Maintained
$210.00
-6.5%
07/22/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$230.00
+2.4%
07/06/2026
Unknown Analyst
DZ BANK AG
Buy
Initiated
$210.00
-6.5%
06/03/2026
Sidharth Sahoo
HSBC
Buy
Maintained
$230.00
+2.4%
06/03/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
06/01/2026
Unknown Analyst
RBC Capital
Buy
Initiated
$200.00
-11%
05/14/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$245.00
+9%
04/22/2026
Ed Ridley-Day
Rothschild & Co Redburn
Hold
Maintained
$205.00
-8.8%
04/17/2026
Unknown Analyst
Goldman Sachs
Buy
Reiterated
$230.00
+2.4%
04/14/2026
Susunod na tawag sa loob ng sa 6 araw
Miy, Okt 21, 2:00 PM
Fiscal period
Q3 2026
- / $1.92
Kita / Pagtataya (USD)
- / 6.56B
Earnings call para sa Fiscal Q3 2026
Hinihintay ang earnings call
Sa isang sulyap: mga paparating na kita
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
6.05B
6.84B
5.95B
6.26B
Gastusin sa mga naibentang produkto
2.53B
2.86B
2.36B
2.61B
Halaga ng kita
2.53B
2.86B
2.36B
2.61B
Mga gastos sa pananaliksik at pag-develop
378.00M
438.00M
387.00M
412.00M
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
1.89B
2.03B
1.84B
2.01B
Gastos sa pagpapatakbo
2.27B
2.46B
2.23B
2.42B
Kabuuang gastos sa pagpapatakbo
4.80B
5.32B
4.59B
5.03B
Kita sa pagpapatakbo
1.26B
1.52B
1.36B
1.24B
Iba pang hindi kita sa pagpapatakbo
-
-87.00M
-
-
EBT na may mga hindi karaniwang item
1.08B
1.37B
1.24B
1.08B
EBT na hindi kasama ang mga hindi karaniwang item
1.19B
1.39B
1.33B
1.19B
Gastos sa buwis sa kita
168.00M
190.00M
206.00M
208.00M
Epektibong rate ng buwis
15.61%
13.84%
16.68%
19.29%
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
908.00M
1.20B
1.03B
870.00M
Margin ng kabuuang kita
15.00%
17.51%
17.29%
13.89%
Kita bawat share
1.89
2.23
2.06
1.94
Kita sa interes at investment
3.00M
13.00M
27.00M
61.00M
Gastos sa interes
-67.00M
-55.00M
-63.00M
-107.00M
Mga net na gastos sa interes
-64.00M
-42.00M
-36.00M
-46.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
1.88B
2.14B
1.99B
1.90B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-9.00M
9.00M
-
-
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google